Navigation Links
GENova discusses development of new anti-cancer biotechs potentially worth $400 Million per annum
Date:9/9/2009

NEW YORK, Sept. 9 /PRNewswire-FirstCall/ - (OTCBB: GVBP.OB) - GENova Biotherapeutics, Inc., ("GENova"), today released important information about its anti-cancer drug development strategy and its unique niche in the drug development industry.

The Company is aggressively acquiring patents involving the latest generation of biotherapeutic technologies that can cure cancer without any side effects.

With a focus on prostate and breast cancers, GENova has acquired a unique class of drugs that utilize stem cell technology to identify, target, and destroy the very originator stem cells that give rise to cancers. These bio-engineered drugs can seek out cancers right at the source, and destroy them whilst leaving healthy tissues intact.

The Company has already filed patents for these drug targets, and has identified similar ones for acquisition. Researchers in academic labs have expressed confidence that this novel approach to treating cancer is the way of the future, and will render current painful treatments obsolete.

John Savin, VP for GENova, explained the Company's unique strategy for penetrating the lucrative drug development industry: "We occupy a strategic point in the drug development and supply chain, as the intermediary between research institutions and the Big Pharmaceutical companies. Our strategy is one of global outsourcing, international collaboration, using the FDA fast track to accelerate drug development, and then early exit to cash-rich and technology-hungry Big Pharma."

Savin said that if GENova's current IP is developed successfully, he estimates that the Company could expect up to $100 Million in milestone payments during clinical trials, and up to $400 Million per annum in the years following commercialization. His estimates are based on evaluations of other successful drug targets in the industry.

Big Pharma presently has $215 Billion to spend on licensing of new drugs, and is eager to feed the
'/>"/>

SOURCE GENova Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. GENova appoints Dr. Anders Boegh Jensen to Scientific Advisory Board
2. Genova files patent for new prostate cancer treatment
3. GENova names Dr. John Savin as Vice President
4. GENova names Aaron Whiteman as CEO
5. Karmanos Chief Cancer Surveillance Researcher Discusses Study on Decreased Cancer Mortality Rates
6. Lumension Sponsored Webinar Discusses Ways to Protect Patient Data and Comply with HIPAA Security Mandates
7. The Caryl Ehrlich Program Discusses Food Addiction on HealthyPlace.com
8. Natural Healers Discusses How Personal Trainer Certification May Be Changing in Some States
9. Natural Healers Discusses How Alternative Medicine Careers Provide a Little 'Wellness' in a Tough Economy
10. Cord Blood America CEO Discusses New State-of-the-Art State Laboratory in Fox News Television Interview
11. All Nursing Schools Discusses Obama's Health Care Reform and Nursing Career Opportunities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... Gerontological Society of America (GSA) the ... aging has chosen Sean P. Curran, PhD, of ... of the Nathan Shock New Investigator Award. , This ... knowledge about aging through basic biological research. It was ... founding member of GSA and pioneer in gerontological research ...
(Date:8/1/2014)... 1, 2014)The use of electronic reminders such as text ... surgical patients to adhere to a preadmission antiseptic showering ... infections (SSIs), according to a first-of-its-kind study published in ... American College of Surgeons . , Each year approximately ... approaching nearly 100,000 according to data sources cited by ...
(Date:8/1/2014)... Plains, NJ (PRWEB) August 01, 2014 ... interactive web portal that aims to empower patients ... role in their health care by providing easy, ... Patient Portal gives patients instant, web-based access to ... laboratory and radiology results, medications, allergies, demographic information, ...
(Date:8/1/2014)... 2014 Ticket Down is a reputable source ... Farms in Knoxville/Greenback, TN; Ingram Farms in Auburn/Opelika, AL; Cross ... Archer/Gainesville, FL. Luke Bryan is currently out on his summer ... Cole Swindell. Bryan is responsible for one of the most ... this year, just because the summer is over doesn’t mean ...
(Date:8/1/2014)... City, NY (PRWEB) August 01, 2014 With ... two incomes, and the convenience of processed, microwavable dinners, it ... Diet Doc does not offer patients a mere quick fix ... helping everyone, in any part of the country, get slimmer ... if they offer patients the tools and education on ...
Breaking Medicine News(10 mins):Health News:Curran to receive GSA's 2014 Nathan Shock New Investigator Award 2Health News:Electronic reminders can help patients prevent surgical site infections 2Health News:Electronic reminders can help patients prevent surgical site infections 3Health News:Chilton Medical Center Launches Online Patient Portal 2Health News:Luke Bryan Tickets at Maple Lane Farms in Knoxville, Ingram Farms in Auburn, Cross Creek Place in Tallahassee & Whitehurst Cattle Farm in Gainesville Now Available 2Health News:Luke Bryan Tickets at Maple Lane Farms in Knoxville, Ingram Farms in Auburn, Cross Creek Place in Tallahassee & Whitehurst Cattle Farm in Gainesville Now Available 3Health News:Luke Bryan Tickets at Maple Lane Farms in Knoxville, Ingram Farms in Auburn, Cross Creek Place in Tallahassee & Whitehurst Cattle Farm in Gainesville Now Available 4Health News:Diet Doc Medical Weight Loss Programs Announces Diet Plans That Melt Excess Fat Rapidly While Teaching Patients How to Avoid Obesity 2Health News:Diet Doc Medical Weight Loss Programs Announces Diet Plans That Melt Excess Fat Rapidly While Teaching Patients How to Avoid Obesity 3
... 29 (HealthDay News) -- Doctors may fail to detect ... having a colonoscopy, a new study warns. On ... stop eating solid food and to consume only clear ... colon. However, previous research suggests that up to ...
... , THURSDAY, March 29 (HealthDay News) -- Psychological and physical ... adolescents, a new survey reveals. Researchers who polled more ... of 11- to 14-year olds had been the victim of ... said they had fallen prey to physical violence while in ...
... HealthDay Reporter , THURSDAY, March 29 (HealthDay News) ... of flavanols -- the antioxidants found in cocoa beans. ... how cocoa might affect blood pressure, heart disease, painful ... presented Wednesday at the American Chemical Society,s annual meeting ...
... key mechanism that causes breast cancer to spread. The research, ... Molecular Cell , enhances our knowledge about the signals ... a lethal form of invasive breast cancer that is notoriously ... has been linked with aggressive forms of breast cancer and ...
... YORK, N.Y. Autism Speaks, the world,s leading autism science ... appointed leaders to immediately develop a new, coordinated strategy to ... epidemic in the wake of a new report from ... is now diagnosed in a staggering 1 in every 88 ...
... The new UK alcohol strategy includes a plan to ensure ... (The Government,s Alcohol Strategy, 23 March 2012, downloadable from ... how much people drink. The big question is, what should ... published online by the scientific journal Addiction analysed ...
Cached Medicine News:Health News:Inadequate Bowel Prep May Invalidate Colonoscopy 2Health News:Dating Violence Common by 7th Grade: Survey 2Health News:Dating Violence Common by 7th Grade: Survey 3Health News:Chocolate a Sweet Remedy for Many Ills? 2Health News:Chocolate a Sweet Remedy for Many Ills? 3Health News:Chocolate a Sweet Remedy for Many Ills? 4Health News:Researchers identify mechanism that makes breast cancer invasive 2Health News:Autism Speaks demands urgent response to the autism epidemic in new CDC prevalence estimates 2Health News:Autism Speaks demands urgent response to the autism epidemic in new CDC prevalence estimates 3
(Date:7/31/2014)... 31, 2014  ResMed Inc. (NYSE: RMD ) ... fiscal year ended June 30, 2014.  Revenue for the quarter ... 30, 2013 (a 1 percent decrease on a constant currency ... percent compared to the quarter ended June 30, 2013. Diluted ... of 22 percent compared to the quarter ended June 30, ...
(Date:7/31/2014)...  Cepheid (NASDAQ: CPHD ) today announced that ... invited investors to participate via webcast. ... NY Wednesday, August 13, 2014 at 9.10 a.m. ... New York, NY Thursday, September 4, 2014 ... Webcasts To access the live webcasts for these events, please ...
(Date:7/31/2014)...  UBM Medica US announces that Cancer ... presents exclusive slide shows dealing with communication in the ... care. Cancer Network, the online ... blogs, and podcasts about the latest clinical findings. Among ... , End-of-life care is challenging for even the ...
Breaking Medicine Technology:RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 2RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 3RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 4RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 5RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 6RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 7RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 8RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 9RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 10RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 11RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 12RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 13Cepheid to Webcast Upcoming Financial Presentations 2Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 2Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 3
Galaxy Single Piece PMMA Lens with UV Absorber....
Liberty Single Piece PMMA Lens with UV Absorber....
Optical implants for the replacement of the human crystalline lens in the visual correction of aphakia....
... II is a sterile nonpyrogenic, transparent viscoelastic ... II contains 12 mg/ml of high molecular ... hyaluronate dissolved in physiological saline. In the ... is 105,000 cps (105 Pa s) at ...
Medicine Products: